Friday 29 th, October 2010
|
|
|
- Molly Bell
- 8 years ago
- Views:
Transcription
1 Friday 29 th, October :00-17:00 Registration 17:00-18:00 Opening Ceremony 18:00-18:30 Refreshment Break 18:30-19:00 Plenary Lecture I Nazli Gad El Mawla Memorial Lecture Chairpersons: Prof. Dr. M. El-Serafy, (NCI,Egypt) Prof. Dr. H. Khaled, (NCI,Egypt) Prof. Dr. H. Elzawahry, (NCI, Egypt) Prof. Dr. A. Abdel Warith, (NCI, Egypt) Prof. Dr. N. El-Lahlouby, (NCI, Egypt) 18:30-19:00 Molecular Targets for Breast Cancer: The Way to Personalized Therapy Prof. Dr. S. Murray, (MMOF - Greece) 19:00-21:00 Pharmaceutical Symposium NOVARTIS SYMPOSIUM (Breast Cancer) 21:30 Opening Ceremony Dinner
2 Saturday 30 th, October :00-09:30 Plenary Lecture II Reda Hamza Memorial Lecture Chairpersons: Prof. Dr. A. Demirkazik, (MMOF, Turkey) Prof. Dr. A. Kandil, (Alexandria University, Egypt) Prof. Dr. Z. Khaled, (NCI, Egypt) Prof. Dr. A. El-Khodary, (NCI, Egypt) Prof. Dr. W.Elmetenawy, (NEMROCK, Egypt) 09:00-09:30 Non Small Cell Lung Cancer: Exploring New Avenues in Tailoring Cancer Treatment Prof. Dr. P. Kosmidis, (MMOF - Greece) 09:30-10:30 Satellite lecture ASTRA ZENECA 10:30-12:00 Session I Malignant Mesothelioma Chairpersons: Prof. Dr. M. Douzinas, (MMOF, Greece) Prof. Dr. A. Bahnassy, (NCI, Egypt) Prof. Dr. B. Hasan, (EORTC, Belgium) Prof. Dr. N. Mokhtar, (NCI, Egypt) Prof. Dr. R. Gaafar, (NCI, Egypt) Prof. Dr. K. Fragia, (MMOF, Greece) Prof. Dr S. El Khatib (KHCC, Jourdan) 10:30-10:45 Epidemiology of Mesothelioma in Egypt and Mediterranean countries Prof. Dr. N. Hassan, (NCI, Egypt) 10:45-11:00 Translational Research and Mesothelioma Prof. Dr. D. Fennell, (EORTC, Ireland) 11:00-11:15 Biomarkers in lung cancer and Mesothelioma Prof. Dr. M. El-Tanani, (Belfast, Ireland) 11:15-11:30 The extended debate of Surgery in Mesothelioma Prof. Dr. A. Abdel Rahman, (NCI, Egypt) 11:30-11:45 Novel agents for malignant mesothelioma Prof. Dr. B.Uluk, (MMOF, Turkey) 11:45-12:00 Discussion 12:00-12:15 Coffee Break 14:15-15:00 Lunch & Poster display 12:15-14:15 Pharmaceutical Symposium ROCHE SYMPOSIUM (Lung Cancer)
3 18:00-18:20 Coffee Breaks 15:00-16:00 Satellite lecture PIERRE FABRE 16:00-18:00 Pharmaceutical Symposium LILLY SYMPOSIUM 18:20-20:20 Session II Hot Topics and Challenges in Lung Cancer Chairpersons: Prof. Dr. B. Biesma, (EORTC, Netherlands) Prof. Dr. H. Elakkad, (Alexandria University, Egypt) Prof. Dr. V. Surmont, (EORTC, Belgium) Prof. Dr. I. Mourad, (NCI, Egypt) Prof. Dr. S. Abel Aziz, (NCI, Egypt) Prof. Dr. M. Helal, (NCI, Egypt) 18:20-18:40 State of art of surgery for NSCLC Prof. Dr. A. Maat, (EORTC, Netherlands) 18:40-19:00 Image guided therapy in lung cancer Prof. Dr. C. Fink, (EORTC, Germany) 19:00-19:20 Implementing Radiation and Systemic Therapy in Stage III NSCLC Prof. Dr. Y. Abdel Kader (NEMROCK, Egypt) 19:20-19:40 Open challenges in the treatment of advanced NSCLC Prof. Dr. R. Gaafar, (NCI, Egypt) 19:40-20:00 Advances in the treatment of SCLC Prof. Dr. M. O Brien, (EORTC, England) 20:00-20:20 Where do we stand in radiotherapy for SCLC? Prof. Dr. H. Abdel Baki, (NCI, Egypt) 20:20-21:00 Plenary Lecture III Highlights on Staging and Maintenance Therapy of NSCLC Chairpersons: Prof. Dr. M. Obrien, (EORTC, England) Prof. Dr. S. El-Mesidi, (NEMROCK, Egypt) Prof. Dr. S.Shamaa, (Mansoura University, Egypt) Prof. Dr. F. Abu Taleb, (Zagazig University, Egypt) Prof. Dr. A.Elkhodary, (NCI, Egypt) 20:20-20:40 Clinical Implications of the IASLC Revised Staging System Prof. Dr. J. VanMeerbeeck, (EORTC, Belgium) 20:40-21:00 Maintenance therapy in advanced NSCLC: Prof. Dr. E. Razis, (MMOF, Greece)
4 21:30 Gala Dinner Sunday 31 st, October :00-10:00 Session III Hall (A) Keynote Lectures Chairpersons: Prof. Dr. P. Papakostas, (MMOF, Greece) Prof. Dr. G. Fountzilas, (MMOF, Greece) Prof. Dr. M. Saber, (NCI, Egypt) Prof. Dr. N. Eldib, (Alexandria University, Egypt) Prof. Dr. N. Anwar, (NCI, Egypt) 09:00-09:30 Breast cancer in Egypt: An overview Prof. Dr. H. Khaled, (NCI, Egypt) 09:30-10:00 Perspectives in the Biology and Management of Inflammatory Breast Cancer Prof.G. Basaran, (MMOF, Turkey) 10:00-11:00 Session IV Hall (A) Advances in Local Therapy for Early Breast Cancer Chairpersons: Prof. Dr. I. Yucel, (MMOF, Turkey) Prof. Dr. P. Skandalakis, (MMOF, Greece) Prof. Dr. S. Omar, (NCI, Egypt) Prof. Dr. S. Al Badawy, (NCI, Egypt) Prof. Dr. W. Yousry, (NCI, Egypt) Prof. Dr. M. Manieh, (NCI, Egypt) Prof. Dr. M. El Naggar, (NCI, Egypt) 10:00-10:20 Innovations in Breast Cancer Surgery Prof. Dr. E. Poulakaki, (MMOF, Greece) Advances in Radiotherapy Prof. Dr. M. El Gentery, (NCI, Egypt) 10:40:11:00 Panel Discussion: Moderator: The Impact of Surgery and Radiotherapy on Quality Of Life in Young Women Prof. Dr Sami ElBadawy 11:00-11:30 Coffee Break
5 11:30-13:00 Session V Hall (A) Advances in Systemic Therapy for Early Breast Cancer Chairpersons: Prof. Dr S. Ismail (Ain Shams, Egypt) Prof. Dr. G. Asimakopoulos, (MMOF, Greece) Prof. Dr. D.Bafaloukos, (MMOF, Greece) Prof. Dr. H. Abdel Azim, (NEMROCK, Egypt) Prof. Dr. T. Hashem, (Menofia University, Egypt) Prof. Dr G.ElHosseiny (Alexandria, Egypt) 11:30-12:00 Controversies in Systemic Therapy of Early Breast Cancer Prof. Dr. N. El-Lahloubi, (NCI, Egypt) 12:00-12:30 Triple Negative Breast Cancer; A Special Entity Prof. Dr. S. Bavbek, (MMOF, Turkey) 12:30-13:00 Translational Research on New Molecular Markers An EORTC BCG Experience 13:00-14:00 Lunch & Poster display 14:00-16:00 Session VI Hall (A) Issues for Better Survival and Quality Of Life in Breast Cancer Chairpersons: Prof. Dr. O. N. Galitis, (MMOF, Greece) Prof. Dr. N. Demesticha, (MMOF, Greece) Prof. Dr. E. Hamada, (NEMROCK, Egypt) Prof. Dr. A. Omar, (Alexandria University, Egypt) Prof. Dr. O. Mansour, (NCI, Egypt) Prof. Dr. H. El Ghazaly, (Ain Shams, Egypt) 14:00-14:30 Neoadjuvant systemic therapy in locally advanced breast Prof. Dr. Y. Eralp, (MMOF-Turkey) 14:30-15:00 Chemotherapy of Advanced Breast Cancer Prof. Dr. A. Christopoulou, (MMOF, Greece) 15:00-15:30 Palliative Care equals better quality of life in MBC Prof. Dr. H. Elzawahry, (NCI, Egypt) 15:30-16:00 Discussion on the Barriers as Challenges for Academic Research 13:00-14:00 Lunch 16:00-17:00 CLOSING REMARKS 08:30-16:00 Hall (B) EORTC Lung Cancer meeting (members only)
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
Special Training Three months training on general thoracic surgery at Emory University,Atlanta, Georgia, USA in
NCI, Kasr El Elini St. Fom El Khalig, Cairo Egypt Mobile : +20100-104 1988 Clinic : +2 239 3 5544 Voice : +2 28406421 Abdelrahman.mohamed@nci.cu.edu.eg Email : rahmannci@yahoo.com Abdel Rahman Mohammed
30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA 17-18 June 2010 Golnik, Slovenia Chair: T. Cufer, SI - G.L. Ceresoli, IT AIM OF THE COURSE The incidence
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Saturday, April 27, 2013 Cleveland Marriott Downtown at Key Center 127 Public Square Cleveland, Ohio Learning
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
2015 Feb.4th. AROME Radiobiology Course and Innovations: from biology to clinical practice of hypo fractionation and Stereotactic Radiotherapy
2015 Feb.4th 19-21 AROME Radiobiology Course and Innovations: from biology to clinical practice of hypo fractionation and Stereotactic Radiotherapy Wyndham Istanbul Kalamis Marina, Turkey www.aromecancer.org
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region April 2016 27-30 Santiago - Chile Hotel Diego de Almagro San Pío X 2530, Providencia, Santiago. INFORMATION www.lungcancerworkshop.cl
PERSONALIZED CANCER TREATMENT A multidisciplinary event
PERSONALIZED CANCER TREATMENT A multidisciplinary event Free Access to the Scientific Sessions March 20 th - 21 st 2015 La Vague de Saint-Paul Saint-Paul de Vence, France Crédit photo Office de Tourisme
Advances in Lung Cancer: A Multidisciplinary Approach
Advances in Lung Cancer: A Multidisciplinary Approach Saturday, April 25, 2015 127 Public Square Cleveland, Ohio Learning Objectives About the Course This one-day course will provide a topical, clinically
British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015
0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals
REPORT ASCO 2002 ORLANDO : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group
REPORT ASCO 2002 ORLANDO : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group In the 2002 edition of the ASCO meeting, a total of 315 abstracts in the field of respiratory
Friday April 8 th 2016
Preliminary Scientific Program - ICTHIC April 8-10, 2016 Friday April 8 th 2016 9,00-11,00 am Industry sponsored session 11,00-11,15 am Congress Opening: A Falanga, FR Rickles, B Brenner 11,15-1,30 pm
Best of San Antonio Breast Cancer Symposium
Best of San Antonio Breast Cancer Symposium 11:45 am - 5:00 pm 5800 Rockside Woods Blvd. About the Course The San Antonio Breast Cancer Symposium is an international meeting of laboratory and clinical
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
The 3 rd Clinical Research Training Course
The 3 rd Clinical Research Training Course Organized By: 07-08 February 2014 Radisson Blu, Jeddah, In Collaboration With: Event Venue: Main : 11 CMEs Hour Diamond Sponsor Silver Bronze Support Registration
Wednesday 27 th January 2016 BTOG Parallel Symposia 11:00 to 14:30 Translational Research Radiotherapy Training Respiratory Medicine Radiology
14 th Annual BTOG Conference 2016 Venue: Doubletree by Hilton Hotel Burlington Road, Dublin Wednesday 27 th to Friday 29 th January 2016 Continuing Professional Development Accreditation will be applied
CLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME
ESO - LATIN-AMERICAN PROGRAMME MASTERCLASS IN CLINICAL ONCOLOGY 25-29 April 2015 São Paulo, Brazil Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT FOREWORD
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians
Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Background The Cancer Institute New South Wales Oncology Group Lung (NSWOG Lung) identified the need for the development
SAKK Lung Cancer Group. Current activities and future projects
SAKK Lung Cancer Group Current activities and future projects SAKK Lung Cancer Group Open group of physicians interested in lung cancer Mostly Medical Oncologists, but also Thoracic Surgeons Radiation
We look forward to both your participation and contribution to this meeting.
Dear Colleagues, It is a great pleasure to invite you to participate in the joint symposium MALIGNANT PLEURAL MESOTHELIOMA: A CHANGING PARADIGM OF CARE organized by Division of Thoracic Surgery, Brigham
Brigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA
Determination of Biomarker Response in a Phase II Window of Opportunity Study of Defactinib (VS 6063), a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Resectable Malignant Pleural Mesothelioma
Summary of treatment benefits
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
How treatment is planned Giving your consent The benefits and disadvantages of treatment Second opinion
Treatment overview for lung cancer This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 5. Contents How
ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN. 8-13 March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS
MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 7 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 8-13 March 2014 Ermatingen
OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 AGENDA
OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 Friday, June 26 AGENDA 10:00 am - 10:45 am Registration; Breakfast
International Conference on Medical Rehabilitation and Prevention of Blindness. November 27 th 29 th, 2015 TENTATIVE SCIENTIFIC PROGRAM
International Conference on Medical Rehabilitation and Prevention of Blindness November 27 th 29 th, 2015 TENTATIVE SCIENTIFIC PROGRAM Pre conference workshop Nov 27 th, 2015 (Friday) Room: Chao Praya2,3,4
The European Haemophilia Consortium (EHC) brings patients and patient organisations together from 44 European countries.
Printer Friendly Information EHC Conference in Belfast 3 rd, 4 th & 5 th October 2014 Introduction The European Haemophilia Consortium (EHC) brings patients and patient organisations together from 44 European
Development of Evidence-Based Nursing in an Interdisciplinary Era: Achievements and Prospects
Organized by the Hariri School of Nursing at the American University of Beirut Development of Evidence-Based Nursing in an Interdisciplinary Era: Achievements and Prospects Overview: In celebration of
May 18, 2013 Sheraton Delfina Santa Monica, California
3rd International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma May 18, 2013 Sheraton Delfina Santa Monica, California Malignant pleural mesothelioma (MPM) is an unusual cancer
Lung Cancer in 2015: A Multidisciplinary Update
Lung Cancer in 2015: A Multidisciplinary Update Invited Guest Faculty: Toronto General Hospital Toronto, Canada Saturday April 18, 2015 7:00 am-4:30 pm Westin Pasadena 191 N. Los Robles Avenue Pasadena,
Regional Young Investigator SIC meeting. 5-6 March 2015
Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita
Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015
Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015 Place: Lecture Hall EKEN, Entrance 65, CAMPUS US, The Faculty of Medicine and Health Science, Linköping University,
The New International Staging System Lung Cancer
The New International Staging System Lung Cancer Valerie W. Rusch, MD Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center Chair, Lung and Esophagus Task Force, American Joint Commission on Cancer
POST-CONGRESS SATELLITE MEETINGS May 24 th, 2013. Cancer biomarkers 2013
20 th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine 45 th Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) POST-CONGRESS SATELLITE
Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France 11-14 September 2008
33 rd European Symposium on Hormones and Cell Regulation Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers Mont Ste. Odile, Alsace, France 11-14 September 2008 Invited Speakers:
ASCO International Clinical Trials Workshop. May 7-8, 2016. Lazzoni Hotel Halic - Istanbul, Turkey
ASCO International Clinical Trials Workshop May 7-8, 2016 Lazzoni Hotel Halic - Istanbul, Turkey Saturday, 7 May 2016 08.30-08.45 Welcome and Introduction Representatives of ASCO, NCI and Turkish Society
Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO
Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO Statistically significant difference in progression-free survival continues to be seen in non-squamous
ESSO Course on Peritoneal Surface Malignancy
ESSO Course on Peritoneal Surface Malignancy In partnership with The Christie School of Oncology 08-09 October 2015 MANCHESTER (UK) ESSO Course on Peritoneal Surface Malignancy Chair: Sarah O Dwyer, The
Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy
Programme Invited Speakers: Reuven Agami (The Netherlands), Manuela Baccarini (Austria), Allan Balmain (USA), Daniel Birnbaum (France), Anne-Lise Børresen-Dale (Norway), Carlos Caldas (UK), Silvana Canevari
The 9th international conference of the International Mesothelioma Interest Group 25 27 September 2008. Amsterdam, The Netherlands
ORGANIZATION The9thinternationalconferenceof theinternationalmesotheliomainterestgroup 2527September2008 Amsterdam,TheNetherlands FINALPROGRAM AND ABSTRACTBOOK AMSTERDAM,2527SEPTEMBER,2008 DEMEERVAART,AMSTERDAM
Mesothelioma 2014. Paul Baas Department of Thoracic Oncology The Netherlands Cancer Institute Amsterdam
Mesothelioma 2014 Paul Baas Department of Thoracic Oncology The Netherlands Cancer Institute Amsterdam Disclosures Grants from Pfizer and Roche Advisor for MSD and Verastem Once upon a time. http://amlbenzene.net/diseases-asbestos.htm
Avastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
Report series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
Malignant Mesothelioma State of the Art
Malignant Mesothelioma State of the Art Paul Baas The Netherlands Cancer Institute August 12, 2011, Carlsbad, CA Summary Diagnosis; epithelial type subdivided Pleiomorphic vs other Staging: IASLC-IMIG
REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM
REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM Valerie Van Damme, Isabelle Wauters, Johan Vansteenkiste Univ. Hospital Leuven and Leuven Lung Cancer Group Introduction Perspectives in Lung Cancer (PILC)
L.N.Gumilyov Eurasian National University
Ministry of Education and Science Republic of Kazakhstan L.N.Gumilyov Eurasian National University THE 15 th ALEXANDER HOLLAENDER COURSE GENOME-ENVIRONMENT INTERACTIONS AND GENETIC TOXICOLOGY September
WEDNESDAY 24 AUGUST 2011
WEDNESDAY 24 AUGUST 2011 08.00-12.00 Set-up of exhibitions Registration desk open 08.00-20.00 11.00-12.00 Nordic Association Nurse Meeting (VIP room) 12.00-13.00 Lunch & Opening of the Exhibition 13.00-14.30
Medical Education Department
Medical Education Department About the Department The department of Medical education, faculty of Medicine, Suez Canal University, is the first department to be founded in medical education in all the
International Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
KOL Insight: Non-small cell lung cancer Game changing immunotherapies to revolutionise treatment
March 2014 KOL Insight: Non-small cell lung cancer A FirstWord Therapy Trends Report KOL Insight: Lung Cancer Published March 2014 Copyright 2014 Doctor s Guide Publishing Limited All rights reserved.
Breast cancer research and a changing treatment pathway
Breast cancer research and a changing treatment pathway Stuart McIntosh Clinical Senior Lecturer in Surgical Oncology, QUB Consultant Breast Surgeon, BCH What is the breast surgeon s role in 2016? Surgery
Lung Cancer & Mesothelioma 2011-2015
Lung Cancer & Mesothelioma 2011-2015 Annex G Mesothelioma 1. The vision for mesothelioma services is set out in the Mesothelioma Framework issued by DH on 26 February 2007 (supported by the British Thoracic
AORTA MASTERCLASS 2015 Preliminary Programme
DAY 1 THURSDAY, 08 th October, 2015 09:30 Registration, tea and coffee 10:00 Welcome B. Sethia - President of The Royal Society of Medicine / RSM, London, UK 10:05 Introduction T. Evans / Royal Brompton
Final announcement Joint meeting in Radiation Biology and Radioecology
Final announcement Joint meeting in Radiation Biology and Radioecology For the Association for Radiation Research in UK, the Swedish Radiobiology Society, the Netherlands Radiobiological Society and the
Big Data in Medicine
Symposium Big Data in Medicine Joint Symposium of the German National Academy of Sciences Leopoldina and the Hasso Plattner Institute for Software Systems Engineering July 1-2, 2015 Hasso Plattner Institute
Amel Abd Allah Hashim Ahmed
Amel Abd Allah Hashim Ahmed Lecturer of Biochemistry & Molecular Biology PERSONAL PROFILE Nationality: Egyptian Work: Faculty of Pharmacy, Helwan University, Ain-Helwan, Helwan, Egypt. Work phone: 25590000-
Third International Conference of Faculty of Pharmacy Cairo University Entitled Good Pharmacy Practice
Third International Conference of Faculty of Pharmacy Cairo Entitled Good Pharmacy Practice Venue: Conference Centre, Cairo Hostel, Giza, Egypt Wednesday, April 25 th, 2012 Opening Session: Hall A 9:00-10:00
Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.
REPORT Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F. Strasser, CH 13-14 March 2015 Barcelona, Spain The Conference Cachexia
Book Public Health in the Arab World Editors: Samer Jabbour, Rita Giacaman, Marwan Khawaja, Iman Nuwayhid Associate Editor: Rouham Yamout
Book Public Health in the Arab World Editors: Samer Jabbour, Rita Giacaman, Marwan Khawaja, Iman Nuwayhid Associate Editor: Rouham Yamout Cambridge University Press (ISBN: 9780521516747) March 2012 Section
Breast Cancer Drug Discoveries: What the Future Holds
Brochure More information from http://www.researchandmarkets.com/reports/679630/ Breast Cancer Drug Discoveries: What the Future Holds Description: In 2010, almost 50% of breast cancer sales were due to
E UROPEAN PERSONAL INFORMATION
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Work Address ARTURO CHITI Humanitas University, Via A. Manzoni 113, 20089 Rozzano (MI), Italy Nuclear Medicine Department, Humanitas Research
Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD
Public Outcomes Report Lung Cancer Submitted by Omar A. Majid, MD Lung cancer is the most common cancer-related cause of death among men and women. It has been estimated that there will be 226,1 new cases
Eastern North Carolina Lung Cancer Symposium
Eastern North Carolina Lung Cancer Symposium Friday, October 30, 2015 The East Carolina Heart Institute 115 Heart Drive Greenville, North Carolina Jointly Provided by The Department of Internal Medicine
Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing
Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But
How To Prepare A Lung Cancer Screening Course
Lung Cancer Screening Course 2015 Friday, May 8th, 2015 Languages: Spanish and English with simultaneous translation 32 International Conference on Lung Cancer Screening Saturday and Sunday, May 9-10,
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
Word of Faculty Of Mass Communication, Cairo University
Word of Faculty Of Mass Communication, Cairo University A word. D. Hassan Emad Mekkawi Irons Dean of the Faculty of Mass Communication Dear colleagues, members of the Faculty of Information and their assistants
10 th EADO Congress Vilnius, 7-10 May 2014. Ipilimumab update. Michele Maio
10 th EADO Congress Vilnius, 7-10 May 2014 Ipilimumab update Michele Maio Medical Oncology and Immunotherapy, Department of Oncology University Hospital of Siena, Istituto Toscano Tumori SIENA, ITALY Evolving
International Symposium on Malignant Mesothelioma
Advocacy - Thursday, June 10 7:30 AM Registration Palladian Foyer 8:00 8:45 AM Welcome and Orientation Breakfast: Effective Advocacy Palladian Room and the Quest for Federal Meso Research Funding 8:45-9:00
Lung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
ESMO 2014 Summary Breast Cancer
ESMO 2014 Summary Breast Cancer 1 7. 1 0. 2 0 1 4 A N NA D U R I G OVA M E D I C A L O N CO LO GY U N I V E R S I T Y H O S P I TA L S O F G E N E VA Outline 1. Early Breast Cancer Her2+ Neoadjuvant: Lapatax
Lung cancer. A guide for journalists on Non-Small Cell Lung Cancer (NSCLC) and its treatment
Lung cancer A guide for journalists on Non-Small Cell Lung Cancer (NSCLC) and its treatment Contents Contents 2 3 Section 1: Lung Cancer 4 i. Types of lung cancer 4 ii. Causes and risk factors 5 iii. Symptoms
Developments in Biomarker Identification and Validation for Lung Cancer
Developments in Biomarker Identification and Validation for Lung Cancer Alexandre Passioukov, MD, PhD Alexandre.Passioukov@eortc.be Contents Introduction Lung cancer pathogenesis NSCLC treatment options
Male. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
May 21, 2011 Sheraton Delfina Santa Monica, California
1st International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma May 21, 2011 Sheraton Delfina Santa Monica, California Malignant pleural mesothelioma (MPM) is an unusual cancer
FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR)
FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 1 st TURKISH-HELLENIC POSTGRADUATE CONTINUOUS MEDICAL EDUCATION MEETING MAY 6-9, 2011, IZMIR, TURKEY DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E.
Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer
Breast Studies Adjuvant therapy after surgery Her 2 positive Breast Cancer B 52 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients with Hormone
How To Treat Mesothelioma With A Tumor Stem Cell Inhibitor
FAK INHIBITOR DEFACTINIB (VS-6063) TARGETS MESOTHELIOMA CANCER STEM CELLS Rationale for maintenance therapy after conventional therapy Jonathan Pachter, Ph.D. Vice President of Research, Verastem, Inc.
POLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
8 11 December 2011 Alexandria, Egypt
II The Second Euro-Med Conference Plant Natural Products from Biodiversity to Bioindustry 8 11 December 2011 The wonderful success of The 1 st Euro-Med Conference on "Plant Natural Products" (BioNat- I)
Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de
It s all about Europe s future with Cloud. EUROCLOUD FORUM 2015. 6 th EuroCloud Congress Barcelona, October 7 9
It s all about Europe s future with Cloud. EUROCLOUD FORUM 2015 6 th EuroCloud Congress Barcelona, October 7 9 EuroCloud Europe is the European umbrella organization of more than 20 national EuroCloud
Climate change adaptation for water, food and environment security
ACLIMAS Follow- up 2 nd Training programme on: Climate change adaptation for water, food and environment security 6 th of October City, Cairo- Egypt 15-17 September 2015 Background In the framework of
Departments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm
4 th Würzburg Summer School of Thyroid Cancer Management A training course on basics, diagnosis and therapy of differentiated thyroid tumours under the auspices of the European Association of Nuclear Medicine
Evolving Challenges in Promoting Cardiovascular Health. November 4-5, 2011, BARCELONA. Final Agenda Feb 2011
Evolving Challenges in Promoting Cardiovascular Health November 4-5, 2011, BARCELONA Final Agenda Feb 2011 SATELLITE PUBLIC LECTURE (LAY PUBLIC): Thursday, November 3, 2011 7:00 8:30 PM Health and Life
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) Szeged,
Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM 2015. Alliance. Innovation PRELIMINARY. Management
OCTOBER 5-6, 2015 PARIS, FRANCE 6 th EDITION THE LEADING PARTNERING MEETING IN OPEN INNOVATION FOR LIFE SCIENCES CONFERENCES EXHIBITION HALL ONE-ON-ONE PARTNERING MEETINGS NETWORKING Open PRELIMINARY PROGRAM
Avastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
I Module Crime Scene & Forensic Genetics
I Module Crime Scene & Forensic Genetics Is a 2 week academic summer programme giving students the opportunity to participate in seminars and tutorials to learn more about criminal investigations. The
I3 Interactions, Integrations and Innovations
Annual Meeting of the German Pharmaceutical Society DPhG I3 Interactions, Integrations and Innovations Düsseldorf, Germany September 23 25, 2015 at Heinrich Heine University Welcome Address Dear colleagues,
Lung cancer is not just one disease. There are two main types of lung cancer:
1. What is lung cancer? 2. How common is lung cancer? 3. What are the risk factors for lung cancer? 4. What are the signs and symptoms of lung cancer? 5. How is lung cancer diagnosed? 6. What are the available
Please see the LUCADA data manual v3.1.3, available in the downloads section
National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands
Lung SSG 6 th May 2015 Research
Lung SSG 6 th May 2015 Research Wendy Cook, Research Delivery Manager dd/mm/yyyy Delivering clinical research to make patients, and the NHS, better South West Peninsula CRN Hospital Yeovil District Hospital
JUNE 2-3, 2014 CONNECT.
JUNE 2-3, 2014 CONNECT. GROW. SUCCEED. THIRD INDUSTRIAL CELL CULTURE TECHNOLOGY CONFERENCE JUNE 2-3, 2014 Laupheim s historical castle, Schloss Großlaupheim, Germany Rentschler Biotechnologie GmbH is delighted
10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7
10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in
Università degli studi di Genova DISEFIN DIPARTIMENTO DI SCIENZE ECONOMICHE E FINANZIARIE
Summer School Euro-Mediterranean relationships: from the Barcelona Agenda to the Union for the Mediterranean" 18 th - 21 st June 2009 Istanbul Technical University, Faculty of Management MACKA 34367 Istanbul